Sage Journals: Discover world-class research

Retricted access

Article commentary

First published 2019-4

Immune-mediated encephalitis with daclizumab: The final nail

Thomas Williams, Jeremy Chataway

Multiple Sclerosis Journal

Retricted access

Case report

First published 2019-4

A case of immune-mediated encephalitis related to daclizumab therapy

Michael Devlin, Andrew Swayne, Martin Newman [...]

Multiple Sclerosis Journal

Free access

Other

First published 2009-09

Long-term daclizumab therapy in relapsing-remitting multiple sclerosis

Monica A. Rojas, Noel G. Carlson, Thomas L. Miller [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Other

First published 2009-02

Daclizumab in treatment of multiple sclerosis patients

EN Ali, BC Healy, LA Stazzone [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2017-1

Daclizumab high-yield process in the treatment of relapsing–remitting multiple sclerosis

Jana Lizrova Preiningerova, Marta Vachova

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2014-2

Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis

Y Zhang, M McClellan, L Efros [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2014-1

The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis

Ron Milo

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2019-10

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis

Lidia Stork, Wolfgang Brück, Phillip von Gottberg [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021

Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination

Ludwig Kappos, Stanley Cohan, Douglas L. Arnold [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2018-5

Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study

Ralph HB Benedict, Stanley Cohan, Sharon G Lynch [...]

Multiple Sclerosis Journal

Search results